FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Objectionable Conditions in Doctors Clinical Trial

FDA warns Lublin, Poland, physician Konrad Rejdak about Bioresearch Monitoring violations in a clinical study for which he was the study director.

latest-news-card-1
Human Drugs

Nowrez & Ismail Shukri CGMP Violations

FDA warns Jordans Nowrez and Ismail Shukri Company about CGMP violations in the production of OTC drugs.

Medical Devices

QS, MDR Violations at Globus Medical

FDA warns Globus Medical about Quality System and Medical Device Reporting violations in its production of the Excelsius GPS surgical robot.

latest-news-card-1
Human Drugs

Proprietary Name Review MAPP

A CDER Manual of Policies and Procedures lists responsibilities for the Office of Surveillance and Epidemiology and other CDER offices dealing with th...

latest-news-card-1
Human Drugs

Tandem Diabetes Insulin Pump App Recall

Tandem Diabetes Care updates its March recall of its Apple iOS t:connect mobile app in the U.S. due to an issue that can cause rapid depletion of a us...

latest-news-card-1
Human Drugs

Creating Hope Reauthorization Act Introduced

Sen Susan Collins and a bipartisan group of her colleagues introduce the Creating Hope Reauthorization Act to extend until 2030 the FDA priority revie...

latest-news-card-1
Human Drugs

Change Biological Drug Monographs: Petition

A University of Illinois Chicago College of Pharmacy petition calls on FDA to authorize a new form of monograph for biological products.

latest-news-card-1
FDA General

Advisors Surveyed on Committee Reforms

3D Communications shares the results from its survey of FDA advisory committee members on committee reform issues.

Medical Devices

Surgical Plannings New HipInsight Cleared

FDA clears a Surgical Planning Associates 510(k) for its new HipInsight 2.0 mixed-reality guidance system for hip arthroplasty.

latest-news-card-1
Human Drugs

Clinical Hold Removed on Dravet Syndrome Drug

FDA removes a partial clinical hold on Stoke Therapeutics zorevunersen (STK-001) and its use in children and adolescents with Dravet syndrome.